One-Year Outcomes of Gonio Scratch as a Minimally Invasive Glaucoma Surgery with Cataract Removal.

Prcis: This study evaluated the 1-year efficacy and safety of a novel minimally invasive glaucoma surgery, gonio scratch, in reducing intraocular pressure of eyes with open-angle glaucoma and cataracts.

Purpose: To evaluate the 1-year efficacy and safety of phacoemulsification cataract extraction combined with gonio scratch (GS-Phaco), a novel minimally invasive glaucoma surgery, in patients with open-angle glaucoma and cataracts.

Patients And Methods: This prospective multicenter clinical trial was conducted at Hiroshima University, Yokoyama Retina Clinic, Kusatsu Eye Clinic, and Miyoshi Eye Clinic in Japan.

The gonio scratch study: methodology of a multicenter clinical trial establishing a new minimally invasive glaucoma surgery.

There are numerous surgical procedures for glaucoma. Minimally invasive glaucoma surgery is becoming popular; however, the disadvantage is the high incidence of anterior chamber hemorrhage. Heavy bleeding can also lead to increased intraocular pressure (IOP) postoperatively.

One-year results of a multicenter controlled clinical trial of triamcinolone in pars plana vitrectomy.

Purpose: To evaluate the 1-year results of using triamcinolone acetonide (TA) in pars plana vitrectomy (PPV).

Design: Multicenter prospective controlled clinical trial.

Setting And Study Population: the study population comprised 774 eyes from patients treated at eight Japanese hospitals, among which 391 eyes underwent TA-assisted PPV and 383 control eyes underwent conventional PPV.

[Case of fungal endophthalmitis developed after subtenon injections of triamcinolone acetonide].

Background: We report a case of fungal endophthalmitis which developed after subtenon injections of triamcinolone acetonide (TA).

Case: A 63-year-old man had Graves' ophthalmopathy. He had received subtenon injections of TA in his left eye.

Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy.

Purpose: To evaluate the benefits and potential complications of using triamcinolone acetonide (TA) in pars plana vitrectomy (PPV).

Design: Multicenter, prospective, controlled clinical trial.

Participants: In total, 774 patients from 8 Japanese hospitals were enrolled, with 391 patients undergoing TA-assisted PPV and 383 control patients undergoing conventional PPV.

Two cases of intraoperative anterior chamber angle observation using ophthalmic endoscope in viscocanalostomy.

Purpose: To report endoscopic findings in the anterior chamber angle during injection of viscoelastic material in viscocanalostomy (VCS).

Design: Observational case reports.

Methods: Two cases of primary open-angle glaucoma were treated with VCS and cataract surgery.

Incidence of acute endophthalmitis after triamcinolone-assisted pars plana vitrectomy.

Purpose: To report the incidence of acute endophthalmitis after triamcinolone acetonide-assisted pars plana vitrectomy (PPV).

Design: A retrospective multicenter interventional case series collected over 23 months.

Methods: We retrospectively reviewed the charts of all patients who underwent triamcinolone-assisted PPV at seven academic clinical centers or eye hospitals from January 2002 to November 2003.

Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.

Objective: To visualize the residual vitreous cortex (VC) on the retinal surface after surgical posterior vitreous separation (PVS) during a pars plana vitrectomy (PPV), especially in patients with diabetic retinopathy.

Design: Case-control study.

Participants: Patients with proliferative diabetic retinopathy (PDR), diabetic macular edema (DME), branch retinal vein occlusion (BRVO), and rhegmatogenous retinal detachment (RRD).